1. Home
  2. ARI vs OCS Comparison

ARI vs OCS Comparison

Compare ARI & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

HOLD

Current Price

$6.28

Market Cap

884.4M

Sector

Real Estate

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$9.41

Market Cap

732.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARI
OCS
Founded
2009
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
884.4M
732.4M
IPO Year
2009
2022

Fundamental Metrics

Financial Performance
Metric
ARI
OCS
Price
$6.28
$9.41
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$11.00
★ $42.00
AVG Volume (30 Days)
★ 2.0M
164.3K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
★ 9.31%
N/A
EPS Growth
★ 183.51
N/A
EPS
★ 0.27
N/A
Revenue
★ $271,589,000.00
N/A
Revenue This Year
N/A
$466.06
Revenue Next Year
N/A
$479.73
P/E Ratio
$23.19
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$6.25
$9.65
52 Week High
$11.24
$34.48

Technical Indicators

Market Signals
Indicator
ARI
OCS
Relative Strength Index (RSI) 21.09 30.57
Support Level N/A $9.65
Resistance Level $7.00 $13.49
Average True Range (ATR) 0.09 0.59
MACD -0.01 -0.08
Stochastic Oscillator 1.52 9.63

Price Performance

Historical Comparison
ARI
OCS

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: